Moxie CEO Hopes to Score Coveted N.J. Medical Pot License
*By Carlo Versano*
The competition is on for new medicinal marijuana licenses in New Jersey after Democratic Gov. Phil Murphy prioritized cannabis production when he took office. The CEO of one potential licensee, Moxie, thinks the state has "passed the tipping point" for accepting medical pot at the state level.
Jordan Lams, founder and CEO of the medicinal marijuana producer, told Cheddar as he awaited news on whether his company had been awarded one of the licenses that Moxie has a fully built-out, 16-acre farm and greenhouse operation at the ready ー which would help New Jersey get its operations up to scale quickly.
"The state can count on us to do what we say we will," he said.
Lams praised Gov. Murphy for "taking ownership" of medical marijuana policy after it had languished under previous administrations.
There is now so much pent-up demand from patients Lams said, that the state has concerns over shortages.
The license that Moxie hopes to win is a fully-integrated, "seed-to-sale" license, though Lams said he will also apply for licenses to just grow and process, if this one is not granted.
Lams, who started a career in medical marijuana after his younger sister died of leukemia, now advocates for responsible regulations in the nascent cannabis industry.
He said he's seeing a market that's "developing every day."
"Every day someone who never would have touched this before is really coming into the marketplace. It's global at this point."
For full interview [click here](https://cheddar.com/videos/moxie-vies-for-nj-medicinal-marijuana-license).
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street. This week we highlight Rivian, Costco, Nokia, Wyndham Hotels & Resorts, Choice Hotels and Rite Aid
Spirit Airlines canceled about 100 flights on Friday after pulling some planes out of service for inspections, and the airline expects the disruptions to last several days.
CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers.
It's almost that time of year - it's open enrollment season. Nate Black, vice president of health solutions product development with Voya Financial, joined Cheddar News to explain the critical decision-making needed when choosing the best coverage for you and your family.
Elon Musk announced two new subscription tiers for people who want the premium experience. This, as some users in some countries may have to pay a very small fee to access the platform for more. Cheddar News' senior reporter Michelle Castillo explains.
